Genomic Landscape of Malignant Mesotheliomas

In conclusion, each individual with malignant mesothelioma harbored a unique set of genomic aberrations, suggesting that NGS-based profiling of patients will be needed if patients are to be optimally matched to cognate treatments. All 42 patients had at least one alteration that was, in theory, pharmacologically tractable. Mol Cancer Ther; 15(10); 2498–507. ©2016 AACR.

Source: Molecular Cancer Therapeutics - October 1, 2016 Category: Cancer & Oncology Authors: Kato, S., Tomson, B. N., Buys, T. P. H., Elkin, S. K., Carter, J. L., Kurzrock, R. Tags: Companion Diagnostics and Cancer Biomarkers Source Type: research